August Bioservices CEO Jenn Adams: ‘We won’t hit a wall’ on growth


“For us this is going to be a continual reassessment of ‘How can we keep adding capacity … and how can we make sure we’re two years ahead of what the demand will be,'" August Bioservices CEO Jenn Adams said.

Previous Charlotte telehealth firm CEO weighs in on the end of Amazon Care
Next Cour Pharmaceuticals secures funding to transform the way allergies and autoimmune disorders are treated